214 related articles for article (PubMed ID: 22120755)
1. Novel insights into the molecular mechanisms of HLA class I abnormalities.
Seliger B
Cancer Immunol Immunother; 2012 Feb; 61(2):249-254. PubMed ID: 22120755
[TBL] [Abstract][Full Text] [Related]
2. The link between MHC class I abnormalities of tumors, oncogenes, tumor suppressor genes, and transcription factors.
Seliger B
J Immunotoxicol; 2014 Oct; 11(4):308-10. PubMed ID: 24479372
[TBL] [Abstract][Full Text] [Related]
3. The role of classical and non-classical HLA class I antigens in human tumors.
Bukur J; Jasinski S; Seliger B
Semin Cancer Biol; 2012 Aug; 22(4):350-8. PubMed ID: 22465194
[TBL] [Abstract][Full Text] [Related]
4. HLA Class I Antigen Processing Machinery Defects in Cancer Cells-Frequency, Functional Significance, and Clinical Relevance with Special Emphasis on Their Role in T Cell-Based Immunotherapy of Malignant Disease.
Seliger B; Ferrone S
Methods Mol Biol; 2020; 2055():325-350. PubMed ID: 31502159
[TBL] [Abstract][Full Text] [Related]
5. Post-transcriptional and epigenetic regulation of antigen processing machinery (APM) components and HLA-I in cervical cancers from Uighur women.
Hasim A; Abudula M; Aimiduo R; Ma JQ; Jiao Z; Akula G; Wang T; Abudula A
PLoS One; 2012; 7(9):e44952. PubMed ID: 23024775
[TBL] [Abstract][Full Text] [Related]
6. HLA class I antigen processing machinery defects in antitumor immunity and immunotherapy.
Maggs L; Sadagopan A; Moghaddam AS; Ferrone S
Trends Cancer; 2021 Dec; 7(12):1089-1101. PubMed ID: 34489208
[TBL] [Abstract][Full Text] [Related]
7. Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation.
Dhatchinamoorthy K; Colbert JD; Rock KL
Front Immunol; 2021; 12():636568. PubMed ID: 33767702
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma?
Atkins D; Ferrone S; Schmahl GE; Störkel S; Seliger B
J Urol; 2004 Feb; 171(2 Pt 1):885-9. PubMed ID: 14713847
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of MHC class I abnormalities and APM components in human tumors.
Seliger B
Cancer Immunol Immunother; 2008 Nov; 57(11):1719-26. PubMed ID: 18408926
[TBL] [Abstract][Full Text] [Related]
10. HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance.
Campoli M; Ferrone S
Oncogene; 2008 Oct; 27(45):5869-85. PubMed ID: 18836468
[TBL] [Abstract][Full Text] [Related]
11. Multiple structural and epigenetic defects in the human leukocyte antigen class I antigen presentation pathway in a recurrent metastatic melanoma following immunotherapy.
Chang CC; Pirozzi G; Wen SH; Chung IH; Chiu BL; Errico S; Luongo M; Lombardi ML; Ferrone S
J Biol Chem; 2015 Oct; 290(44):26562-75. PubMed ID: 26381407
[TBL] [Abstract][Full Text] [Related]
12. Role of Human Leukocyte Antigen System as A Predictive Biomarker for Checkpoint-Based Immunotherapy in Cancer Patients.
Sabbatino F; Liguori L; Polcaro G; Salvato I; Caramori G; Salzano FA; Casolaro V; Stellato C; Col JD; Pepe S
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023239
[TBL] [Abstract][Full Text] [Related]
13. Association of IFN-gamma signal transduction defects with impaired HLA class I antigen processing in melanoma cell lines.
Respa A; Bukur J; Ferrone S; Pawelec G; Zhao Y; Wang E; Marincola FM; Seliger B
Clin Cancer Res; 2011 May; 17(9):2668-78. PubMed ID: 21248298
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic changes within the promoter regions of antigen processing machinery family genes in Kazakh primary esophageal squamous cell carcinoma.
Sheyhidin I; Hasim A; Zheng F; Ma H
Asian Pac J Cancer Prev; 2014; 15(23):10299-306. PubMed ID: 25556465
[TBL] [Abstract][Full Text] [Related]
15. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
[TBL] [Abstract][Full Text] [Related]
16. Evolution of studies of HLA class I antigen processing machinery (APM) components in malignant cells.
Sabbatino F; Schwab JH; Ferrone S; Ferrone CR
Clin Transpl; 2013; ():453-63. PubMed ID: 25095541
[TBL] [Abstract][Full Text] [Related]
17. Deficient expression of components of the MHC class I antigen processing machinery in human cervical carcinoma.
Ritz U; Momburg F; Pilch H; Huber C; Maeurer MJ; Seliger B
Int J Oncol; 2001 Dec; 19(6):1211-20. PubMed ID: 11713591
[TBL] [Abstract][Full Text] [Related]
18. Molecular and functional phenotypes of melanoma cells with abnormalities in HLA class I antigen expression.
Wang Z; Margulies L; Hicklin DJ; Ferrone S
Tissue Antigens; 1996 May; 47(5):382-90. PubMed ID: 8795138
[TBL] [Abstract][Full Text] [Related]
19. WHO grade associated downregulation of MHC class I antigen-processing machinery components in human astrocytomas: does it reflect a potential immune escape mechanism?
Mehling M; Simon P; Mittelbronn M; Meyermann R; Ferrone S; Weller M; Wiendl H
Acta Neuropathol; 2007 Aug; 114(2):111-9. PubMed ID: 17541610
[TBL] [Abstract][Full Text] [Related]
20. The SPPL3-Defined Glycosphingolipid Repertoire Orchestrates HLA Class I-Mediated Immune Responses.
Jongsma MLM; de Waard AA; Raaben M; Zhang T; Cabukusta B; Platzer R; Blomen VA; Xagara A; Verkerk T; Bliss S; Kong X; Gerke C; Janssen L; Stickel E; Holst S; Plomp R; Mulder A; Ferrone S; Claas FHJ; Heemskerk MHM; Griffioen M; Halenius A; Overkleeft H; Huppa JB; Wuhrer M; Brummelkamp TR; Neefjes J; Spaapen RM
Immunity; 2021 Jan; 54(1):132-150.e9. PubMed ID: 33271119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]